EGFR-EMT is primarily induced via the MEK-ERK1/2 pathway [39, 48], which suggested a possible positive-feedback loop between EGFR and CD73 in regulating EMT in HNSCC that converges at the MAPK level. Here, MAPK3 is linked to head and neck squamous cell carcinoma.